Literature DB >> 20040048

The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study.

Jean-Marie Trawalé1, Valérie Paradis, Pierre-Emmanuel Rautou, Claire Francoz, Sylvie Escolano, Marion Sallée, François Durand, Dominique Valla, Didier Lebrec, Richard Moreau.   

Abstract

BACKGROUND/
OBJECTIVE: Little is known on the morphological changes in the kidneys of cirrhotic patients with abnormal urinalysis and/or high serum creatinine levels. This retrospective, one-point-in-time study aimed to report the results of the analysis of renal biopsy specimens obtained in patients with cirrhosis.
METHODS: We retrieved information on 65 patients who underwent transvenous renal biopsy for proteinuria >0.5 g/day and/or microscopic haematuria and/or unexplained renal impairment (defined by serum creatinine levels >1.5 mg/dl).
RESULTS: Fifty-one per cent of the patients had proteinuria >0.5 g/day, 58% had haematuria and 83% had renal impairment. Renal biopsy disclosed injury to glomeruli in 77% of the patients, to vessels in 69% and to the tubulointerstitium system in 94% (chronic in 77%; acute in 75%). Fibrous endarteritis was the most common renal vascular lesion. Injuries to different structures were frequently combined. Isolated glomerular alterations were found in only two patients. Acute tubular necrosis was significantly more common in patients with fibrous endarteritis than in those without. Among 18 patients with renal impairment, proteinuria <0.5 mg/day and no haematuria, 10 had glomerular lesions, 13 had chronic tubulointerstitial lesions and 12 acute tubulointerstitial lesions.
CONCLUSION: In patients with cirrhosis, various types of renal injuries are frequently combined. Chronic lesions (vascular or tubulointerstitial) may influence the outcome, in particular in patients who subsequently undergo liver transplantation and receive anticalcineurins. Renal vascular lesions may increase the risk of acute tubular necrosis. In patients with renal impairment, the absence of significant proteinuria and haematuria do not rule out the presence of renal lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20040048     DOI: 10.1111/j.1478-3231.2009.02182.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  35 in total

Review 1.  Treatment and management of ascites and hepatorenal syndrome: an update.

Authors:  Kurt Lenz; Robert Buder; Lisbeth Kapun; Martin Voglmayr
Journal:  Therap Adv Gastroenterol       Date:  2015-03       Impact factor: 4.409

Review 2.  [Renal insufficiency in patients with hepatic insufficiency].

Authors:  K Lenz; M Binder; R Buder; A Gruber; B Gutschreiter; M Voglmayr
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04-26       Impact factor: 0.840

3.  Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: evidence for a nonfunctional mechanism of hepatorenal syndrome.

Authors:  Vicente Arroyo
Journal:  Hepatol Int       Date:  2017-01-25       Impact factor: 6.047

Review 4.  [Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].

Authors:  K Lenz; R Buder; G Lohr; P Piringer; M Voglmayr
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-05-30       Impact factor: 0.840

Review 5.  Acute kidney injury in acute on chronic liver failure.

Authors:  Rakhi Maiwall; S K Sarin; Richard Moreau
Journal:  Hepatol Int       Date:  2015-10-15       Impact factor: 6.047

Review 6.  The evolving concept of acute kidney injury in patients with cirrhosis.

Authors:  Florence Wong
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-10-20       Impact factor: 46.802

7.  Dopamine and Furosemide for the Treatment of Hepatorenal Syndrome: A Reappraisal or Just Smoke and Mirrors?

Authors:  Salvatore Piano; Paolo Angeli
Journal:  J Clin Exp Hepatol       Date:  2015-12-06

8.  Clinical value of urinary retinol-binding protein in ascites due to cirrhosis.

Authors:  Yujing Xia; Jingjing Li; Sainan Li; Tong Liu; Yuqing Zhou; Qin Yin; Jianrong Wang; Wenxia Lu; Rong Zhang; Yuanyuan Zheng; Fan Wang; Jie Lu; Kan Chen; Weiqi Dai; Yingqun Zhou; Chuanyong Guo
Journal:  Exp Ther Med       Date:  2017-09-22       Impact factor: 2.447

Review 9.  Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.

Authors:  Louise Madeleine Risør; Flemming Bendtsen; Søren Møller
Journal:  Hepatol Int       Date:  2014-09-27       Impact factor: 6.047

Review 10.  Sepsis-induced acute kidney injury in patients with cirrhosis.

Authors:  Paolo Angeli; Marta Tonon; Chiara Pilutti; Filippo Morando; Salvatore Piano
Journal:  Hepatol Int       Date:  2015-07-04       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.